STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #59 by analyst upside · 2026-08-13
MDCX
Medicus Pharma Ltd.
Healthcare · Market Cap $19M · P/E 0x
ANALYST PRICE TARGET
+1259.1%
implied upside to consensus target
Current Price $0.33
Consensus Target $4.5
Bull Target $9.0
Bear Target $1.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
0
Sell
0
52-Week Low $0.25
52-Week High $3.05
YTD Return -79.3%
FUNDAMENTALS
Market Cap $19M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.63
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.25
52-Week High $3.05
Current Price $0.33
Bear Target $1.0
Bull Target $9.0
● Now $0.33 ● Target $4.5
TRADING DATA
Avg Volume 2.0M
YTD Return -79.3%
Analyst Count 4
Consensus Buy
Upside to Target +1259.1%
Last Updated 2026-08-13

ANALYST SUMMARY

Medicus Pharma Ltd. (MDCX) is currently trading at $0.33 with a Wall Street consensus price target of $4.5, implying potential upside of 1259.1% over the next 12 months. 4 analysts currently cover MDCX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $9.0, while the most cautious has a target of $1.0.

MDCX operates in the Healthcare sector with a market capitalisation of $19M. The stock is down 79.3% year-to-date and is currently trading near the lower end of its 52-week range of $0.25 – $3.05.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MDCX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

D. Boral Capital - Reiterated
Buy → Buy 2026-04-20 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2026-03-19 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2026-03-09 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2025-12-15 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2025-11-17 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2025-11-13 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2025-10-29 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2025-10-22 32% win rate (25 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →